Literature DB >> 28762079

Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis.

Zaher K Otrock1, Karl G Hock2, Sarah B Riley3, Theo de Witte4, Charles S Eby2, Mitchell G Scott2.   

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a rare, potentially fatal, syndrome of excessive and ineffective activation of the immune system. The majority of the reported data on HLH is from pediatric patients and lacks specificity. This makes HLH diagnosis challenging especially in adults where HLH is triggered by many conditions and can resemble many disease entities. Elevated ferritin is one of the diagnostic criteria for HLH. We determined the conditions associated with elevated ferritin at our medical center to assess how specific ferritin is for predicting HLH. We retrospectively reviewed all ferritin results >10,000 μg/L in pediatric and adult patients. The most common condition associated with elevated ferritin was hematologic malignancy in adults (25.7%) and HLH in pediatric patients (48.9%). HLH was diagnosed in 14.2% of adults and 48.9% of children with ferritin >10,000 µg/L. Hyperferritinemia occurs in a variety of conditions and is not specific for adult or pediatric HLH. Common causes of elevated ferritin should be considered before entertaining the possibility of HLH, especially in adult patients.

Entities:  

Keywords:  Adults; Diagnosis; Ferritin; Hemophagocytic lymphohistiocytosis; Pediatrics; Specific

Mesh:

Substances:

Year:  2017        PMID: 28762079     DOI: 10.1007/s00277-017-3072-0

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  18 in total

1.  Clinical analysis and a novel risk predictive nomogram for 155 adult patients with hemophagocytic lymphohistiocytosis.

Authors:  Mengxin Lu; Yanghao Xie; Xiaoxu Guan; Ming Wang; Lin Zhu; Shen Zhang; Qin Ning; Meifang Han
Journal:  Ann Hematol       Date:  2021-05-12       Impact factor: 3.673

Review 2.  Pediatric hemophagocytic lymphohistiocytosis.

Authors:  Scott W Canna; Rebecca A Marsh
Journal:  Blood       Date:  2020-04-16       Impact factor: 22.113

3.  Pneumococcal Bacteremia Complicated by Hemophagocytic Lymphohistiocytosis.

Authors:  Frederick Howard; Christopher Sankey
Journal:  J Gen Intern Med       Date:  2019-04-22       Impact factor: 5.128

4.  [Relationship between marked hyperferritinemia and hemophagocytic lymphohistiocytosis].

Authors:  W B Gao; M J Shi; H Y Zhang; C B Wu; J H Zhu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-10-18

5.  The first case of Streptococcus intermedius brain abscess with hemophagocytic histiocytosis.

Authors:  Jia Zhang; Jianjun Wang; Jing Gan; Rong Luo; Xiaolu Chen
Journal:  BMC Infect Dis       Date:  2022-07-18       Impact factor: 3.667

6.  An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis.

Authors:  Adi Zoref-Lorenz; Jun Murakami; Liron Hofstetter; Swaminathan Iyer; Ahmad S Alotaibi; Shehab Fareed Mohamed; Peter G Miller; Elad Guber; Shiri Weinstein; Joanne Yacobovich; Sarah Nikiforow; Benjamin L Ebert; Adam Lane; Oren Pasvolsky; Pia Raanani; Arnon Nagler; Nancy Berliner; Naval Daver; Martin Ellis; Michael B Jordan
Journal:  Blood       Date:  2022-02-17       Impact factor: 25.476

7.  Brucellosis accompanied by haemophagocytic lymphohistiocytosis and multiple splenic abscesses in a patient with depression.

Authors:  Fatehi E Elzein; Nisreen Al Sherbini; Mohammed M Alotaibi; Wassiem M Al-Hassan
Journal:  BMJ Case Rep       Date:  2018-03-27

Review 8.  Current Flow Cytometric Assays for the Screening and Diagnosis of Primary HLH.

Authors:  Samuel Cern Cher Chiang; Jack J Bleesing; Rebecca A Marsh
Journal:  Front Immunol       Date:  2019-07-23       Impact factor: 7.561

Review 9.  Hyperferritinemia-A Clinical Overview.

Authors:  Miriam Sandnes; Rune J Ulvik; Marta Vorland; Håkon Reikvam
Journal:  J Clin Med       Date:  2021-05-07       Impact factor: 4.241

10.  Haemophagocytic Lymphohistiocytosis with Leptospirosis: A Rare but Devastating Complication.

Authors:  B M Munasinghe; A G Arambepola; N Pathirage; U P M Fernando; N Subramaniam; S Nimalan; T Gajanthan
Journal:  Case Rep Infect Dis       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.